PHP
GH icon

Parkman Healthcare Partners’s Guardant Health GH Stock Holding History

Parkman Healthcare Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-89,329
Closed -$3.81M – 90
2025
Q1 		$3.81M Buy
+89,329
New +$3.85M 0.45% 60
2023
Q1 		– Sell
-35,000
Closed -$952K – 89
2022
Q4 		$952K Buy
+35,000
New +$1.6M 0.25% 73
2020
Q1 		– Sell
-30,250
Closed -$2.36M – 70
2019
Q4 		$2.36M Buy
+30,250
New +$2.18M 0.68% 46

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Parkman Healthcare Partners's GH Position: Q2 2025 in Review

Parkman Healthcare Partners sold out of Guardant Health (GH) in Q2 2025, closing a stake of 89,329 shares — an estimated $3.81M sold.

Parkman Healthcare Partners first reported a position in GH in Q4 2019 and held it in 3 quarters. The position peaked at $3.81M in Q1 2025. 364 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Parkman Healthcare Partners reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 89,329 Guardant Health shares in Q2 2025, an estimated $3.81M.
  • Parkman Healthcare Partners first reported a position in Guardant Health in Q4 2019 and held it in 3 quarters.
  • Parkman Healthcare Partners's Guardant Health position peaked at $3.81M in Q1 2025.
  • 364 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.